Business Standard

Ajanta Pharma hits new high on stake hikes by promoter

Gabs Investments Pvt Ltd, one of its promoters has acquired 115,431 shares via creeping acquisition route since April

Related News

Ajanta Pharma has rallied over 5% to Rs 712, its lifetime high, after the promoter acquired almost 1% stake in the company through open market purchases.

Gabs Investments Pvt Ltd, one of its promoters has acquired 115,431 shares representing 0.98% stake in the company via route since April, according to disclosure made by the company on Monday.

The promoters hiked their stake by 3.31% to 70.13% in the last financial year ended March 2012.

Meanwhile, the stock has outperforming the market by gaining 32%, compared with 3.6% fall in the benchmark index, after reporting 52% year-on-year growth in net profit at Rs 77 crore for the quarter ended March 2012.

The company’s board of directors have recommended a dividend @ Rs 7.50 per share for the financial year 2011-12 and also splitting of its equity share of Rs 10 each in to 2 equity shares of Rs 5 each.

A combined 95,687 shares have changed hands on the counter so far on both the exchanges.

 

Read more on:   
|
|

Ajanta Pharma hits new high on stake hikes by promoter

Gabs Investments Pvt Ltd, one of its promoters has acquired 115,431 shares via creeping acquisition route since April

Ajanta Pharma has rallied over 5% to Rs 712, its lifetime high, after the promoter acquired almost 1% stake in the company through open market purchases.

Ajanta Pharma has rallied over 5% to Rs 712, its lifetime high, after the promoter acquired almost 1% stake in the company through open market purchases.

Gabs Investments Pvt Ltd, one of its promoters has acquired 115,431 shares representing 0.98% stake in the company via route since April, according to disclosure made by the company on Monday.

The promoters hiked their stake by 3.31% to 70.13% in the last financial year ended March 2012.

Meanwhile, the stock has outperforming the market by gaining 32%, compared with 3.6% fall in the benchmark index, after reporting 52% year-on-year growth in net profit at Rs 77 crore for the quarter ended March 2012.

The company’s board of directors have recommended a dividend @ Rs 7.50 per share for the financial year 2011-12 and also splitting of its equity share of Rs 10 each in to 2 equity shares of Rs 5 each.

A combined 95,687 shares have changed hands on the counter so far on both the exchanges.

 

image

Read More

Agri Min proposes Rs 170/quintal hike in paddy MSP

In view of rising farm input costs, the Agriculture Ministry has proposed a Rs 170 per quintal increase in the minimum support price (MSP) of paddy ...

Recommended for you

Quick Links

Market News

Nickel rises by 0.1% on Asian cues

Traders strengthened positions amid a firming Asian cues

Oil prices rise further in Asia

Expectations of a decline in US crude inventories and robust economic data from the eurozone helped prices

Markets remain rangebound; HUL up over 2%, Hindalco dips 1%

Investors are optimistic about a possible solution between Greece and its international creditors to avert a debt crisis

Pharma shares in focus; Aurobindo Pharma hits new high

JB Chemicals, Alembic Pharma, Aurobindo Pharma, Ipca Laboratories and Dishman Pharma were up 3%-11% each.

Infinite Computer gains on board approval for share buyback proposal

The stock spurted 5% at Rs 171 after the board approved the buyback of shares at a maximum price of Rs 220 per share from the open market ...

 

Back to Top